These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 105698)

  • 1. Sideroblastic anaemia and leukaemia in multiple myeloma.
    Phadke KP; Kwan YL; Young SG
    Aust N Z J Med; 1978 Oct; 8(5):539-43. PubMed ID: 105698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sideroblastic anemia in a multiple myeloma treated by melphalan (author's transl)].
    Phelip X; Grosclaude S; Rouge P; Mouries D; Blanc D
    Sem Hop; 1979 Oct 18-25; 55(35-36):1633-5. PubMed ID: 231836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Letter: Multiple myeloma, sideroblastic anemia and acute leukemia.
    Law IP; Plovnick HS; Beddow DG
    N Engl J Med; 1976 Jan; 294(3):164. PubMed ID: 1244516
    [No Abstract]   [Full Text] [Related]  

  • 4. Sideroblastic anemia in multiple myeloma: a preleukemic change.
    Khaleeli M; Keane WM; Lee GR
    Blood; 1973 Jan; 41(1):17-25. PubMed ID: 4118108
    [No Abstract]   [Full Text] [Related]  

  • 5. Myelopathies during the course of multiple myeloma.
    Economopoulos T; Pappa V; Panani A; Stathakis N; Dervenoulas J; Papageorgiou E; Asprou N; Raptis S
    Haematologica; 1991; 76(4):289-92. PubMed ID: 1794735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Letter: Refractory sideroblastic anemia and malignant hemopathies].
    Gardais J
    Nouv Presse Med; 1975 Mar; 4(9):670. PubMed ID: 1168900
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute leukemia in multiple myeloma.
    Gonzalez F; Trujillo JM; Alexanian R
    Ann Intern Med; 1977 Apr; 86(4):440-3. PubMed ID: 403840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ["Non-secreting" plasma cell myeloma preceded by refractory sideroblastic anemia (author's transl)].
    Moreau L; Cosson A; Valcke JC; Preud'homme JL; Philbert M; Favriel JM
    Sem Hop; 1979 Nov 18-25; 55(39-40):1794-6. PubMed ID: 232775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgE-type multiple myeloma with the late development of IgA2 kappa and plasma cell leukaemia.
    Chiu W; Pullon H; Woon ST; Oei P; The R; Ameratunga R
    Pathology; 2010 Jan; 42(1):82-4. PubMed ID: 20025486
    [No Abstract]   [Full Text] [Related]  

  • 10. [Multiple myeloma transforming into acute leukaemia (author's transl)].
    Mayans J; Redon J; Badia L; Herranz C; Calabuig JR; Sanz MA; Soler A; Caballero M; Marty ML
    Sangre (Barc); 1977; 22(6):1026-9. PubMed ID: 601670
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dysmyelopoietic syndrome 7 years after melphalan treatment of multiple myeloma. Clinical case].
    Scolozzi R; Boccafogli A
    Minerva Med; 1983 Jul; 74(28-29):1783-5. PubMed ID: 6866310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Refractory anemia with partial myeloblastosis in multiple myeloma treated with melphalan].
    Morlock G; Bataille R; Sany J; Serre H
    Sem Hop; 1977 Apr 9-16; 53(14-15):853-6. PubMed ID: 194338
    [No Abstract]   [Full Text] [Related]  

  • 13. Sideroblastic anaemia and its association with leukaemia and myelomatosis: a report of five cases.
    Catovsky D; Shaw MT; Hoffbrand AV; Dacie JV
    Br J Haematol; 1971 Apr; 20(4):385-93. PubMed ID: 5279616
    [No Abstract]   [Full Text] [Related]  

  • 14. Sideroblastic anemia as a preleukemic event in patients treated for Hodgkin's disease.
    Kitahara M; Cosgriff TM; Eyre HJ
    Ann Intern Med; 1980 May; 92(5):625-7. PubMed ID: 6770730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Simultaneous occurrence of acute leukemia and multiple myeloma].
    Niskanen E; Vuopio P
    Duodecim; 1975; 91(17):1026-9. PubMed ID: 1061668
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial.
    Gay F; Oliva S; Petrucci MT; Conticello C; Catalano L; Corradini P; Siniscalchi A; Magarotto V; Pour L; Carella A; Malfitano A; Petrò D; Evangelista A; Spada S; Pescosta N; Omedè P; Campbell P; Liberati AM; Offidani M; Ria R; Pulini S; Patriarca F; Hajek R; Spencer A; Boccadoro M; Palumbo A
    Lancet Oncol; 2015 Dec; 16(16):1617-29. PubMed ID: 26596670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [IgM myeloma].
    Assaf ME; Pizzolato MA; De María HE; Gasparini S; Burucua JE
    Sangre (Barc); 1983; 28(5):642-7. PubMed ID: 6420914
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cutaneous plasmacytomas following treatment of IgA kappa multiple myeloma].
    Ortín X; Llorente A; Martínez S; Ugarriza A
    Med Clin (Barc); 2004 Oct; 123(15):597-8. PubMed ID: 15535948
    [No Abstract]   [Full Text] [Related]  

  • 19. Coexisting kappa light chain multiple myeloma and primary hyperparathyroidism.
    Toussirot E; Bille F; Henry JF; Acquaviva PC
    Scand J Rheumatol; 1994; 23(1):49-50. PubMed ID: 8108668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosomal abnormalities and dyserythropoiesis in the preleukaemic phase of multiple myeloma.
    Dahlke MB; Nowell PC
    Br J Haematol; 1975 Sep; 31(1):111-6. PubMed ID: 1212431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.